Waystar (NASDAQ:WAY – Get Free Report) and DIAGNOS (OTCMKTS:DGNOF – Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.
Profitability
This table compares Waystar and DIAGNOS’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Waystar | 11.18% | 7.03% | 4.75% |
| DIAGNOS | -7,014.89% | N/A | -192.10% |
Earnings and Valuation
This table compares Waystar and DIAGNOS”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Waystar | $1.10 billion | 4.61 | $112.09 million | $0.70 | 37.71 |
| DIAGNOS | $50,000.00 | 825.73 | -$3.30 million | ($0.04) | -8.53 |
Waystar has higher revenue and earnings than DIAGNOS. DIAGNOS is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current recommendations for Waystar and DIAGNOS, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Waystar | 1 | 2 | 20 | 3 | 2.96 |
| DIAGNOS | 0 | 0 | 0 | 0 | 0.00 |
Waystar currently has a consensus price target of $35.52, suggesting a potential upside of 34.55%. Given Waystar’s stronger consensus rating and higher probable upside, research analysts clearly believe Waystar is more favorable than DIAGNOS.
Volatility & Risk
Waystar has a beta of 0.06, meaning that its stock price is 94% less volatile than the S&P 500. Comparatively, DIAGNOS has a beta of -0.11, meaning that its stock price is 111% less volatile than the S&P 500.
Summary
Waystar beats DIAGNOS on 12 of the 13 factors compared between the two stocks.
About Waystar
Waystar Holding Corp. is a software company which provide healthcare payments. Waystar Holding Corp. is based in LEHI, Utah.
About DIAGNOS
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
